The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: Implications for urinary stone pathogenesis

Molecular Medicine

Volumn 8, Issue 4, 2002, Pages 200-209

  Grover, Phulwinder K ^a   Kim, Dong Sun ^a   Ryall, Rosemary Lyons ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE DIBASIC; HYDROXYAPATITE; OXALIC ACID; PHOSPHATE;

ARTICLE; BARNACLE; CONTROLLED STUDY; COULTER COUNTER; CRYSTALLIZATION; HUMAN; IN VITRO STUDY; MALE; PATHOGENESIS; PHYSIOLOGY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; URINE; UROLITHIASIS; X RAY ANALYSIS;

EID: 0036042611     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402012     Document Type: Article

References (55)

1. The frequency of urolithiasis in hospital discharge diagnoses in the United States
2. Epidemiological risk factors in calcium stone disease
3. Demographic and geographic variability of kidney stones in the United States
4. The changing pattern of urolithiasis in the UK and its causes
5. Economic impact of urolithiasis in the United States
6. Composition and structure of urinary stone
7. Structure and composition of urinary calculi
8. The aetiology of renal stones: A new concept arising from studies in a stone-free population
9. Present concepts concerning the origin of matrix and stones
10. Evaluation of factors involved in calcium stone formation
11. Experimental research on parallel growth on mutual orientation of crystals of different species
12. Epitaxy as a growth factor in urinary calculi and gallstones
13. Human stones: Limited studies give some details of composition, rates of growth, distribution, and possible causes
14. Activity products in stone-forming and non-stone-forming urine
15. Nucleation and growth of brushite and calcium oxalate in urine of stone formers
16. Hydroxyapatite - The forgotten crystal in calcium urolithiasis
17. Urinary supersaturation with respect to brushite in patients suffering from calcium oxalate lithiasis
18. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment
19. Hydroxyapatite and its role in calcium urolithiasis
20. Recurrent stone formation in patients treated with ESWL
21. Calcium phosphate: An important crystal phase in patients with recurrent calcium stone formation?
22. Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate
23. Epitaxial relationships in urolithiasis: The calcium oxalate monohydrate-hydroxyapatite system
24. Epitaxial relationships in urolithiasis: The brushite-whewellite system
25. Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system
26. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals
27. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs
28. Epitaxis between stone-forming crystals at atomic level
29. Induced crystal growth of calcium oxalate monohydrate at hydroxyapatite surfaces. The influence of human serum albumin, citrate and magnesium
30. In vitro formation of "urinary stones": Generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization
31. The influence of hydroxyapatite seed on the crystallization induced by volume reduction of solutions with an ion composition corresponding to that in the distal tubule at different pH levels
32. Urinary protein effects on heterogeneous nucleation of calcium oxalate on hydroxyapatite
33. Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrix
34. Calcium phosphate crystal-associated proteins: Alpha 2-HS-glycoprotein, prothrombin F1, and osteopontin
35. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: A highly selective phenomenon
36. The effect of low-speed centrifugation and millipore filtration on the urinary protein content
37. Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine
38. Prevention and treatment of kidney stones
39. Chemical factors governing the state of saturation towards brushite and whewellite in urine of calcium stone formers
40. Calcium crystalluria in recurrent renal-stone formers
41. The solubility of bone mineral. II. Precipitation of near neutral solutions of calcium and phosphate
42. Spontaneous precipitation of brushite in urine: Evidence that brushite is the nidus of renal stones originating as calcium phosphate
43. Physicochemical basis for formation of renal stones of calcium phosphate origin: Calculation of the degree of saturation of urine with respect to brushite
44. Potential etiological role for brushite in the formation of calcium (renal) stones
45. 2+
46. Glycosaminoglycans, proteins, and stone formation: Adult themes and child's play
47. The calcium oxalate growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin
48. Osteopontin inhibits nucleation of calcium oxalate crystals
49. Simple method for the study of heterogeneous nucleation in calcium oxalate urolithiasis
50. Effect of seed crystals of uric acid and monosodium urate on the crystallization of calcium oxalate in undiluted human urine in vitro
51. Calcium phosphate/calcium oxalate crystal association in urinary stones: Implications for heterogeneous nucleation of calcium oxalate
52. The effect of seed crystals on calcium oxalate nucleation